Innov Clin Neurosci. 2026;23(1–3):10–16. by Larrilyn Grant, MD, MS; Lexi Singh, BS; and Anisha Mandava, MS All authors are with the Wright State, University Boonshoft School of Medicine Department of
Innov Clin Neurosci. 2026;23(1–3):17–22. by Kenny Nguyen, PharmD; Tammie Lee Demler, PharmD, MBA, BCGP, BCPP; and Eileen Trigoboff, PMHCNS-BC, DNS, DABFN Drs. Nguyen and Demler are with The New York
Innov Clin Neurosci. 2026;23(1–3):27–31. by Vatsala Sharma, MD; Vimala Sim, MD, MBA; and Maria Chona P. San Gabriel, MD, DFAPA All authors are with Department of Psychiatry, Icahn School of
Innov Clin Neurosci. 2026;23(1–3):32–38. by Humphrey Masimba Makumbirofa, MSc; Tariro Tsitsidzashe Hluyo, BPharm; Jonathan Chaweza, BTech; Simbarashe Wandayi, MVPG, BVSc; and Nyarai Desiree Soko, PhD, MSc Messrs. Makumbirofa, Hluyo, Chaweza,
Innov Clin Neurosci. 2026;23(1–3):39–46. by Steven Wickens, MPsych, and Trevor Brown, PhD Both authors are with Neurocare Group, Melbourne, Australia. FUNDING: No funding was provided for this article. DISCLOSURES: The
Gut Microbiota as a Therapeutic Target for Chronic Pain Disorders
Innov Clin Neurosci. 2025;23(1–3):23–26. by Takahiko Nagamine, MD, PhD Dr. Nagamine is with the Department of Psychiatric Internal Medicine, Sunlight Brain Research Center, Hofu, Japan. FUNDING: No funding was provided
Read More